Antimicrobial Peptides Market Size, Share & Trends Analysis Report By Product (Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Insect Antimicrobial Peptides), By Ailments, By Route of Administration, By End User, By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034

Report Id: 2335 Pages: 180 Last Updated: 15 May 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Antimicrobial Peptides Market:

Antimicrobial Peptides Market By Product

  • Plant Antimicrobial Peptides
  • Bacterial Antimicrobial Peptides
  • Animal Antimicrobial Peptides
  • Insect Antimicrobial Peptides

Antimicrobial Peptides Market Seg

Antimicrobial Peptides Market By Ailments

  • Pneumonia
  • Hepatitis
  • Bacterial infections
  • HIV

Antimicrobial Peptides Market By Route of Administration

  • Topical
  • Subcutaneous
  • Intravenous

Antimicrobial Peptides Market By End User

  • Pharma and Healthcare
  • Agriculture Industry
  • Biological Engineering
  • Others

Antimicrobial Peptides Market By Distribution Channel

  • Hospital
  • Research Institutes
  • Specialty Clinic
  • Pharmacies

Antimicrobial Peptides Market By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Antimicrobial Peptides Market Snapshot

Chapter 4. Global Antimicrobial Peptides Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis

5.1. by Product Type & Market Share, 2024 & 2034

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:

5.2.1. Plant Antimicrobial Peptides

5.2.2. Bacterial Antimicrobial Peptides

5.2.3. Animal Antimicrobial Peptides

5.2.4. Insect Antimicrobial Peptides

Chapter 6. Market Segmentation 2: by Ailments Estimates & Trend Analysis

6.1. by Ailments & Market Share, 2024 & 2034

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Ailments:

6.2.1. Pneumonia

6.2.2. Hepatitis

6.2.3. Bacterial infections

6.2.4. HIV

Chapter 7. Market Segmentation 3: by Route of Administration Estimates & Trend Analysis

7.1. by Route of Administration & Market Share, 2024 & 2034

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Route of Administration:

7.2.1. Topical

7.2.2. Subcutaneous

7.2.3. Intravenous

Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis

8.1. By End User & Market Share, 2024 & 2034

8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:

8.2.1. Pharma and Healthcare

8.2.2. Agriculture Industry

8.2.3. Biological Engineering

8.2.4. Others

Chapter 9. Market Segmentation 5: by Distribution Channel Estimates & Trend Analysis

9.1. by Distribution Channel & Market Share, 2024 & 2034

9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Distribution Channel:

9.2.1. Hospital

9.2.2. Research Institutes

9.2.3. Specialty Clinic

9.2.4. Pharmacies

Chapter 10. Antimicrobial Peptides Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Antimicrobial Peptides Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034

10.1.2. North America Antimicrobial Peptides Market Revenue (US$ Million) Estimates and Forecasts by Ailments, 2021-2034

10.1.3. North America Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034

10.1.4. North America Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034

10.1.5. North America Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034

10.1.6. North America Antimicrobial Peptides Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

10.2. Europe

10.2.1. Europe Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034

10.2.2. Europe Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034

10.2.3. Europe Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034

10.2.4. Europe Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034

10.2.5. Europe Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034

10.2.6. Europe Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034

10.3. Asia Pacific

10.3.1. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034

10.3.2. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034

10.3.3. Asia-Pacific Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034

10.3.4. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034

10.3.5. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034

10.3.6. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034

10.4. Latin America

10.4.1. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034

10.4.2. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034

10.4.3. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034

10.4.4. Latin America Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034

10.4.5. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034

10.4.6. Latin America Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034

10.5. Middle East & Africa

10.5.1. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034

10.5.2. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034

10.5.3. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034

10.5.4. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034

10.5.5. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034

10.5.6. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances

11.2. Company Profiles

11.2.1. Novozymes A/S

11.2.2. Polypeptide Group

11.2.3. Bachem Holding AG

11.2.4. Wuxi Apptec

11.2.5. Ana Spec Inc. (a Eurofins Company)

11.2.6. Merial

11.2.7. Ipsen S.A.

11.2.8. AstraZeneca

11.2.9. Pfizer Inc.

11.2.10. GlaxoSmithKline plc

11.2.11. Merck & Co. Inc.

11.2.12. Sandoz International GmbH

11.2.13. Polymedia

11.2.14. Magennis Inc.

11.2.15. Probiotic Limited

11.2.16. Eli Lilly and Company

11.2.17. Johnson & Johnson Private Limited

11.2.18. Melinta Therapeutics, LLC

11.2.19. Vertex Pharmaceuticals Incorporated

11.2.20. AMP Biotech

11.2.21. Phoenix Biotechnology Inc.

11.2.22. Novabiotics

11.2.23. Other prominent players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
8428
Security Code field cannot be blank!

Frequently Asked Questions

Antimicrobial Peptides Market Size is valued at USD 248.53 Mn in 2024 and is predicted to reach USD 759.86 Mn by the year 2034

Antimicrobial Peptides Market is expected to grow at an 11.9% CAGR during the forecast period for 2025-2034.

Polymedia, Magennis Inc., Probiotic Limited Melinta Therapeutics, LLC, Vertex Pharmaceuticals Incorporated, AMP Biotech, Phoenix Biotechnology Inc., O

Antimicrobial Peptides Market is categorized on the basis of product , ailments distribution channel, route of administration and end users .

North America region is leading the Antimicrobial Peptides Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying